Psychological distress, such as depression and anxiety, has been intensively studied in patients with systemic lupus erythematosus (SLE). However, those studies have mostly included patients who were treated with corticosteroids, which might themselves induce mood disturbances. We investigated psychological distress in corticosteroid-naive patients with SLE who did not exhibit any overt neuropsychiatric manifestations.
Methods
Forty-three SLE in-patients with no current or past abnormal neuropsychiatric history participated in the study. Patients and 30 healthy control subjects with similar demographic and personality characteristics were administered a comprehensive battery of psychological/neuropsychological tests. The Profile of Mood States (POMS) was used to assess depression and anxiety. Results of clinical, laboratory, and neurological tests were compared with regard to their presence.
Results
Prevalence of depression was higher in patients (n = 11, 25.6%) than in controls (n = 2, 6.7%; p = 0.035), although prevalence of anxiety did not differ across groups (patients: 34.9%, n = 15; controls: 16.7%, n = 5; p = 0.147). Using multiple logistic regression analysis, we identified avoidance coping methods (OR, 1.3; 95% CI 1.030–1.644; p = 0.027) as an independent risk factor for depression.
Conclusion
Our results indicate that depression presents more frequently in corticosteroid-naive patients with early-stage, active SLE than in the normal population, but anxiety does not. Depression may be related to psychological reactions to suffering from the disease.
ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
2.
HanlyJGUrowitzMBSuL. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis2010; 69: 529–535.
3.
AinialaHHietaharjuALoukkolaJ. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum2001; 45: 419–423.
4.
ArnettFCReveilleJDMoutsopoulosHMGeorgescuLElkonKB. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum1996; 39: 1833–1839.
5.
LaptevaLNowakMYarboroCH. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum2006; 54: 2505–2514.
6.
MakATangCSHoRC. Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus. Lupus2013; 22: 254–261.
7.
GiovacchiniGMoscaMMancaG. Cerebral blood flow in depressed patients with systemic lupus erythematosus. J Rheumatol2010; 37: 1844–1851.
8.
LangoschJRandSGhoshB. A clinical electrophysiological study of emotional lability in patients with systemic lupus erythematosus. J Neuropsychiatry Clin Neurosci2008; 20: 201–209.
9.
BachenEAChesneyMACriswellLA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum2009; 61: 822–829.
10.
ZakeriZShakibaMNarouieBMladkovaNGhasemi-RadMKhosraviA. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int2012; 32: 1179–1187.
11.
JarpaEBabulMCalderónJ. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus2011; 20: 58–66.
12.
van ExelEJacobsJKorswagenLA. Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus2013; 22: 1462–1469.
13.
KheirandishMFaeziSTParagomiP. Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients. Mod Rheumatol2015; 25: 405–409.
14.
HuangXMagderLSPetriM. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol2014; 41: 1823–1833.
15.
IshikuraRMorimotoNTanakaK. Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol2001; 20: 394–400.
16.
ShortallEIsenbergDNewmanSP. Factors associated with mood and mood disorders in SLE. Lupus1995; 4: 272–279.
17.
WaterlooKOmdalRHusbyGMellgrenSI. Emotional status in systemic lupus erythematosus. Scand J Rheumatol1998; 27: 410–414.
18.
SeguíJRamos-CasalsMGarcía-CarrascoM. Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. Lupus2000; 9: 584–588.
19.
KarolDECriscione-SchreiberLGLinMClowseME. Depressive symptoms and associated factors in systemic lupus erythematosus. Psychosomatics2013; 54: 443–450.
20.
WaldheimEElkanACPetterssonS. Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus2013; 22: 1118–1127.
21.
BrownES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy Ann NY Acad Sci2009; 1179: 41–55.
22.
NishimuraKOmoriMSatoE. New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study. J Neurol2014; 261: 2150–2158.
23.
BrownESSuppesTKhanDACarmodyTJ. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol2002; 22: 55–61.
24.
MakATangCSChanMFCheakAAHoRC. Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus. Clin Rheumatol2011; 30: 795–803.
25.
NishimuraKOmoriMKatsumataY. Neurocognitive impairment in corticosteroid-naive patients with active systemic lupus erythematosus: A prospective study. J Rheumatol2015; 42: 441–448.
26.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
27.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press, 2000.
28.
FirstMBSpitzerRLGibbonMSpizerRSWilliamsJBW. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition (SCID-I/NP), New York: Biometrics Research, New York State Psychiatric Institute, 2002.
29.
McNairDMLorrMDropplemanLF. Manual for the Profile of Mood Status (POMS), revised, San Diego, CA: San Diego Educational and Industrial Testing Service (EdITS), 1992.
30.
YokoyamaKArakiSKawakamiNTakeshitaT. Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity. Jpn J Public Health1990; 37: 913–918 (in Japanese).
31.
CostaPTMcCraeRR. Revised NEO Personality Inventory (NEO-PI-R) and the NEO Five Factor Inventory (NEO-FFI) Professional Manual, Odessa, FL: Psychological Assessment Resourses, 1992.
32.
DigmanJM. Personality structure: Emergence of the five-factor model. Annu Rev Psychol1990; 41: 417–440.
33.
SpinhovenPPeneloEde RooijMPenninxBWOrmelJ. Reciprocal effects of stable and temporary components of neuroticism and affective disorders: results of a longitudinal cohort study. Psychol Med2014; 44: 337–348.
34.
KoorevaarAMComijsHCDhondtAD. Big Five personality and depression diagnosis, severity and age of onset in older adults. J Affect Disord2013; 151: 178–185.
35.
NamirSWolcottDLFawzyFI. Social support and HIV spectrum disease: clinical and research perspectives. Psychiatr Med1989; 7: 97–105.
36.
FawzyFICousinsNFawzyNWKemenyMEElashoffRMortonD. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry1990; 47: 720–725.
LezakMD. Neuropsychological assessment, 3rd edn. New York: Oxford University Press, 1995.
39.
Abe M, Suzuki K, Okada K, et al. Normative data on tests for frontal lobe functions: Trail Making Test, Verbal fluency, Wisconsin Card Sorting Test (Keio version) No To Shinkei. 2004; 56: 567–574 (in Japanese).
40.
KashimaHKatoMHandaT. Neuropsychological studies on frontal lobe function of the patients with chronic schizophrenia. Results of application of the new modified Wisconsin Card Sorting Test. Rinsho Seishin Igaku (Japan J Clin Psychiatry)1985; 14: 1479–1489. (in Japanese).
KozoraEHanlyJGLaptevaLFilleyCM. Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. Arthritis Rheum2008; 58: 3286–3298.
43.
MeszarosZSPerlAFaraoneSV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry2012; 73: 993–1001.
44.
PetriMNaqibuddinMCarsonKA. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol2010; 37: 2032–2038.
45.
MarianGNicaEAIonescuBECarlogeaDG. Depression as an initial feature of systemic lupus erythematosus? A case report. J Med Life2010; 3: 183–185.
46.
HawroTKrupińska-KunMRabe-JabłońskaJ. Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. Rheumatol Int2011; 31: 1387–1391.
47.
PalaginiLMoscaMTaniCGemignaniAMauriMBombardieriS. Depression and systemic lupus erythematosus: a systematic review. Lupus2013; 22: 409–416.
48.
McCrackenLMSemenchukEMGoetschVL. Cross-sectional and longitudinal analyses of coping responses and health status in persons with systemic lupus erythematosus. Behav Med1995; 20: 179–187.
49.
KozoraEEllisonMCWaxmonskyJAWamboldtFSPattersonTL. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus2005; 14: 363–372.
50.
HyphantisTPalierakiKVoulgariPVTsifetakiNDrososAA. Coping with health-stressors and defence styles associated with health-related quality of life in patients with systemic lupus erythematosus. Lupus2011; 20: 893–903.
51.
SutantoBSingh-GrewalDMcNeilHP. Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken)2013; 65: 1752–1765.
52.
KarlsonEWLiangMHEatonH. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum2004; 50: 1832–1841.
53.
HauptMMillenSJännerMFalaganDFischer-BetzRSchneiderM. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis2005; 64: 1618–1623.
